Cargando…
The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
mRNA-based technologies have been of interest for the past few years to be used for therapeutics. Several mRNA vaccines for various diseases have been in preclinical and clinical stages. With the outbreak of the COVID-19 pandemic, the emergence of mRNA vaccines has transformed modern science. Recent...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668227/ https://www.ncbi.nlm.nih.gov/pubmed/34916811 http://dx.doi.org/10.2147/IDR.S341694 |
_version_ | 1784614525005201408 |
---|---|
author | Nitika, Wei, Jiao Hui, Ai-Min |
author_facet | Nitika, Wei, Jiao Hui, Ai-Min |
author_sort | Nitika, |
collection | PubMed |
description | mRNA-based technologies have been of interest for the past few years to be used for therapeutics. Several mRNA vaccines for various diseases have been in preclinical and clinical stages. With the outbreak of the COVID-19 pandemic, the emergence of mRNA vaccines has transformed modern science. Recently, two major mRNA vaccines have been developed and approved by global health authorities for administration on the general population for protection against SARS-CoV-2. They have been proven to be successful in conferring protection against the ongoing SARS-CoV-2 and its emerging variants. This will draw attention to various mRNA vaccines against infectious diseases that are in the early stages of clinical trials. mRNA vaccines offer several advantages ranging from rapid design, generation, manufacturing, and administration and have strong potential to be used against various diseases in the future. Here, we summarize the mRNA-based vaccines in development against various infectious diseases. |
format | Online Article Text |
id | pubmed-8668227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-86682272021-12-15 The Development of mRNA Vaccines for Infectious Diseases: Recent Updates Nitika, Wei, Jiao Hui, Ai-Min Infect Drug Resist Review mRNA-based technologies have been of interest for the past few years to be used for therapeutics. Several mRNA vaccines for various diseases have been in preclinical and clinical stages. With the outbreak of the COVID-19 pandemic, the emergence of mRNA vaccines has transformed modern science. Recently, two major mRNA vaccines have been developed and approved by global health authorities for administration on the general population for protection against SARS-CoV-2. They have been proven to be successful in conferring protection against the ongoing SARS-CoV-2 and its emerging variants. This will draw attention to various mRNA vaccines against infectious diseases that are in the early stages of clinical trials. mRNA vaccines offer several advantages ranging from rapid design, generation, manufacturing, and administration and have strong potential to be used against various diseases in the future. Here, we summarize the mRNA-based vaccines in development against various infectious diseases. Dove 2021-12-09 /pmc/articles/PMC8668227/ /pubmed/34916811 http://dx.doi.org/10.2147/IDR.S341694 Text en © 2021 Nitika et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Nitika, Wei, Jiao Hui, Ai-Min The Development of mRNA Vaccines for Infectious Diseases: Recent Updates |
title | The Development of mRNA Vaccines for Infectious Diseases: Recent Updates |
title_full | The Development of mRNA Vaccines for Infectious Diseases: Recent Updates |
title_fullStr | The Development of mRNA Vaccines for Infectious Diseases: Recent Updates |
title_full_unstemmed | The Development of mRNA Vaccines for Infectious Diseases: Recent Updates |
title_short | The Development of mRNA Vaccines for Infectious Diseases: Recent Updates |
title_sort | development of mrna vaccines for infectious diseases: recent updates |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668227/ https://www.ncbi.nlm.nih.gov/pubmed/34916811 http://dx.doi.org/10.2147/IDR.S341694 |
work_keys_str_mv | AT nitika thedevelopmentofmrnavaccinesforinfectiousdiseasesrecentupdates AT weijiao thedevelopmentofmrnavaccinesforinfectiousdiseasesrecentupdates AT huiaimin thedevelopmentofmrnavaccinesforinfectiousdiseasesrecentupdates AT nitika developmentofmrnavaccinesforinfectiousdiseasesrecentupdates AT weijiao developmentofmrnavaccinesforinfectiousdiseasesrecentupdates AT huiaimin developmentofmrnavaccinesforinfectiousdiseasesrecentupdates |